If you experience any severe reactions, contact your healthcare provider
The FDA's Pharmacy Compounding Advisory Committee reviewed it under Section 503A of the Federal Food, Drug, and Cosmetic Act as part of the agency's evaluation of bulk drug substances used in compounding.
Some people have concerns about using hormones because previous studies showed higher rates of heart disease, breast cancer, blood clots, and stroke with their use, says Dr
For a dual-use company navigating this landscape, the question is rarely whether an opportunity exists
10.1016/j.numecd.2021.03.00733975736 145 Hou X, Cen K, Zhu Y, et al